Mink Therapeutics Inc (INKT) Financials

$12.00

$-0.13 (-1.07%)

As on 11-Sep-2026 16:00EDT

Market cap

$59 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

11.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	2,704.74	--
Cost of Revenue	0.15	0.18	0.22	0.20	0.12	0.08
Gross Profit	-0.15	-0.18	-0.22	-0.20	-0.12	-0.08
Operating Expenses	12.21	12.31	10.43	22.72	30.83	18.53
Operating Profit (EBIT)	-12.36	-12.49	-10.65	-22.92	-30.95	-18.61
Other Income	--	--	--	--	2.70	--
Profit before Tax	-11.36	-12.49	-10.78	-22.46	-27.99	-30.21
Provision for Tax	--	--	-10,774.02	0.00	-3.21	-7.10
Profit after Tax (Net Income)	-11.36	-12.49	-10.78	-22.46	-27.99	-30.21
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-27.99	-30.21

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-14.03	-14.23	-19.59	-18.06	-0.40	23.78
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	16.07	15.44	18.35	11.21	9.19	3.00
Current Liabilities	7.57	13.03	6.96	11.40	12.68	16.47
Total Liabilities	17.18	14.24	5.72	4.55	21.47	40.24

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.32	0.39	0.73	0.95	1.07	0.61
Current Assets	9.30	13.85	4.99	3.60	20.40	39.63
Total Assets	18.91	14.24	5.72	4.55	21.47	40.24
Total Debt*	--	5.18	4.92	--	--	--
Net Current Assets	--	0.82	-1.97	-7.80	7.72	23.17

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5.93	-9.56	-15.76	-18.87	-12.83
Cash Flow from Investing Activities	--	--	--	-0.07	-0.25	-0.25
Cash from Financing Activities	--	14.72	10.82	-0.41	-0.16	49.26
Net Cash Inflow / Outflow	--	--	--	--	-19.27	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.45	-2.93	-2.86	-6.50	-8.28	-9.19
Cash EPS ($)	--	-2.88	-2.80	-6.44	-8.24	-9.17
Adjusted Book Value ($)	--	--	--	--	--	7.24
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.39	-2.53	-4.56	-5.58	-3.90
Free Cash Flow per Share ($)	--	-1.39	-2.53	-4.58	-5.65	-3.98

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	105.39	65.93	243.36	-239.50	-440.22
ROE (%)	--	73.90	57.30	243.36	-239.50	200.76
ROA (%)	-65.74	-125.20	-209.96	-172.59	-90.71	-134.89
EBIT Margin (%)	--	--	--	--	-1.03	--
Net Margin (%)	--	--	--	--	-1.03	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	--	--
EBIT Growth (%)	-1.48	-15.85	51.98	19.77	-0.76	-101.34
Net Profit Growth (%)	-0.76	-15.85	51.98	19.77	7.35	-86.05
EPS Growth (%)	14.57	-0.02	0.56	0.22	0.10	-0.61
Book Value Growth (%)	55.85	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.81	-0.24	-0.16	-0.32	-0.49
Price / Book Value	11.33	-3.35	-0.13	-0.20	-21.99	0.62
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.67	-3.20	432.33	-0.01	0.39	0.87
Close Price ($)	11.69	11.15	6.97	10.70	26.10	44.60
High Price ($)	76.00	76.00	19.00	33.40	49.40	221.55
Low Price ($)	6.80	4.56	4.63	8.50	10.90	37.00
Market Cap ($ Cr)	59.40	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.36	-0.25	--	--	--
Short term debt to equity ratio	--	-0.36	--	--	--	--
Current Ratio	1.23	1.06	0.72	0.32	1.61	2.41
Quick Ratio	1.23	--	--	--	--	2.41
Interest Coverage	--	--	--	--	-110.50	-11.42

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	87.66	--
Receivable days	--	--	--	--	0.00	--
Inventory Days	--	--	--	--	5.28	2,419.43
Payable days	--	6,183.32	5,628.86	8,688.67	13,228.08	14,377.36
Cash Conversion Cycle	--	--	--	--	-13,222.79	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.